Biocon

Biocon closer to receiving nod for LatAm entry
DNA India, India
Sat, 01/24/15 - 10:08 am
Biocon
Roche wins battle against India sales of generic cancer drug
FT.com
Fri, 02/7/14 - 09:40 am
Roche
India
breast cancer
biosimilars
Biocon
Mylan
Biocon to start selling breast cancer drug in India in February
Yahoo/Reuters
Sat, 01/18/14 - 11:21 am
Biocon
breast cancer
trastuzumab
generics
Herceptin
Mylan, Biocon help market generic insulin drugs
Yahoo/AP
Thu, 02/14/13 - 10:18 am
Biocon
Mylan
generics
diabetes
insulin
Lantus
Humalog
Novolog
Biocon, Bristol-Myers in deal for oral insulin drug
Reuters
Fri, 11/16/12 - 10:10 am
Biocon
Bristol-Myers Squibb
insulin
diabetes
IN-105
Abbott, Biocon to develop nutrition products for India
Reuters
Thu, 05/3/12 - 11:03 am
India
nutrition
Biocon
Abbott Laboratories
Pfizer's $200 Million Mistake
Motley Fool
Thu, 03/15/12 - 09:11 am
Pfizer
Biocon
insulin
diabetes
Novo Advances as Pfizer Drops Diabetes Deal
Bloomberg
Tue, 03/13/12 - 11:05 am
Novo Nordisk
Biocon
insulin
Pfizer
diabetes
Biocon Plunges After Ending Pfizer Insulin Distribution Pact
Bloomberg
Tue, 03/13/12 - 11:03 am
Pfizer
Biocon
insulin
diabetes
Biocon Rises After Starting Manufacture of Lipitor Ingredients
Bloomberg
Tue, 09/13/11 - 10:16 am
Biocon
Lipitor
Pfizer
Malaysia
Can Biocon get a $1B pharma deal for its oral insulin program?
Fierce Biotech
Wed, 06/15/11 - 09:01 am
insulin
diabetes
Biocon
India
Sanofi
Bristol-Myers Squibb
Bristol-Myers Squibb, Sanofi-Aventis in race for drug marketing pact with Biocon
Economic Times, India
Tue, 06/14/11 - 09:13 am
Bristol-Myers Squibb
Sanofi
India
Biocon
Biocon Says Revenue From Pfizer Deal to Begin in Fiscal 2012
Bloomberg
Thu, 01/20/11 - 11:15 am
Biocon
Pfizer
Biosimilar threat tarnishes Novo's star status
Reuters
Tue, 10/19/10 - 11:07 am
Novo Nordisk
insulin
biosimilars
Biocon
Pfizer
Biocon Surges on $200 Million Payment From Pfizer for Biosimilar Insulin
Bloomberg
Tue, 10/19/10 - 09:17 am
Pfizer
Biocon
insulin
biosimilars
Pfizer Goes Super-Generic
Forbes
Mon, 10/18/10 - 11:09 am
Pfizer
generics
insulin
Biocon
diabetes
M&A
Pfizer Acquires Rights to Biocon Insulin Products for $200 Million Upfront
Bloomberg
Mon, 10/18/10 - 09:54 am
M&A
Pfizer
Biocon
insulin
Biocon Gains in Mumbai After Report It May Sell Drug to Pfizer
Bloomberg
Fri, 10/8/10 - 08:08 am
India
Biocon
Pfizer
insulin
Biocon May Sell Oral Diabetes Drug to Pfizer, Bloomberg UTV Says
Bloomberg
Thu, 10/7/10 - 07:01 am
Biocon
Pfizer
diabetes
insulin
Amylin and Biocon say they will work together to develop diabetes drug combining 2 hormones
Yahoo/AP
Fri, 09/11/09 - 08:24 am
Amylin
Biocon
partnerships
diabetes

Pages